Bhasin, N., Kumar Sharma, M., Yadav, D.N. and Kumar Kumawat, D.M. 2022. Diabetes Ketoacidosis Is a Cause of Concern in Sodium-Glucose Co-Transporter-2 Inhibitors Medication: Pharmaceutical Science-Pharmaceutics. International Journal of Life Science and Pharma Research. 13, SP 1 (Dec. 2022), P55-P67. DOI:https://doi.org/10.22376/ijlpr.2023.13.SP1.P55-P67.